George Green, Bristol Myers Squibb

 

George Green joins Beyond the Scope to discuss the pharmaceutical industry's perspective on digital pathology and artificial intelligence. The conversation revolves around how digital pathology will see increased applications in the current era of precision medicine. (posted April 2021)


 

 

Please log in to your DPA profile to submit comments

 

RELATED CONTENT

PODCAST

Staci Kearney, Elevation Strategic Development

Season 2 Episode 11

LISTEN NOW

PODCAST

Chen Sagiv, DeePathology

Season 1 Episode 12

LISTEN NOW

PODCAST

Mike Isaacs, WashU Pathology

Season 3 Episode 8

LISTEN NOW
Chat bot